Chemicals · Founded 1990 · www.seya.in · BSE 524324 · NSE SEYAIND · ISIN INE573R01012
No Notes Added Yet
Business
Seya Industries Ltd. operates in the chemicals sector in India. The company is primarily involved in the manufacturing of various chemical products. While specific product portfolios can vary, chemical companies typically produce a range of specialty chemicals, intermediates, or bulk chemicals that serve as raw materials for other industries such as pharmaceuticals, agrochemicals, dyes, textiles, paints, plastics, and various industrial applications. Seya Industries likely generates revenue by manufacturing these chemicals and selling them to B2B customers, who then use them in their own production processes.
Revenue Mix
Without specific financial reports, the exact breakdown of Seya Industries' key segments and revenue mix is not publicly available here. Chemical companies often segment their operations based on product categories (e.g., specialty chemicals, performance chemicals, intermediates), end-use applications (e.g., pharma, agro, industrial), or geographical markets. For a chemical manufacturer, revenue is typically derived from the sales of its manufactured chemical products to a diverse customer base across different industrial sectors.
Industry
The Indian chemicals industry is diverse, competitive, and growing, driven by domestic consumption, manufacturing growth, and export opportunities. It comprises both large multinational corporations and numerous domestic players, ranging from large integrated companies to smaller, specialized manufacturers. Seya Industries likely operates within a specific niche or a set of product lines within this broad industry. Its positioning relative to peers would depend on factors like its product specialization, production capacity, technological capabilities, customer relationships, and cost efficiency. Companies in this sector can differentiate themselves through product quality, technical support, regulatory compliance, and supply chain reliability.
MOAT
For a chemical company like Seya Industries, potential competitive advantages (moats) could include:
Process Know-how & Efficiency: Proprietary manufacturing processes or significant scale that allows for cost-effective production.
Product Specialization/Formulation: Developing unique or highly specialized chemical compounds that are difficult for competitors to replicate.
Regulatory Approvals & Compliance: Holding necessary certifications and adhering to stringent environmental and safety regulations, which can be a barrier to entry.
Customer Relationships & Switching Costs: Long-term contracts and deep integration with customer supply chains can create high switching costs for buyers.
Backward Integration: Control over raw material sourcing, reducing supply chain risks and potentially improving cost structures.
Without specific information, it's not possible to definitively state which of these Seya Industries possesses.
Growth Drivers
Key factors that could drive growth for Seya Industries over the next 3-5 years include:
Growth in End-User Industries: Increased demand from sectors like pharmaceuticals, agrochemicals, textiles, and automotive, which use Seya's chemicals as inputs.
Import Substitution: Government initiatives and domestic industry push to reduce reliance on imported chemicals.
Capacity Expansion: Investing in new production facilities or expanding existing ones to meet rising demand.
Product Diversification & R&D: Developing new chemical compounds or improving existing ones to tap into new markets or applications.
Export Opportunities: Leveraging competitive manufacturing costs to cater to international markets.
Risks
Seya Industries faces several business risks:
Raw Material Price Volatility: Fluctuations in the prices of crude oil derivatives or other key feedstocks can impact production costs and profitability.
Environmental & Regulatory Risks: Strict environmental protection laws, evolving regulations, and compliance costs can pose significant operational and financial challenges.
Intense Competition: The presence of numerous domestic and international players can lead to pricing pressures and margin erosion.
Demand Fluctuations: Economic downturns or slowdowns in key end-user industries can reduce demand for chemical products.
Technological Obsolescence: Rapid advancements in chemical processes or new product innovations could render existing products or methods less competitive.
Foreign Exchange Risk: For companies involved in imports/exports, currency fluctuations can impact costs and revenues.
Management & Ownership
In India, many listed companies, especially in traditional manufacturing sectors, are promoter-led. This typically means a founding family or group holds a significant stake and plays a crucial role in management and strategic decisions. Ownership structure usually involves a substantial promoter holding, with the remaining shares held by institutional investors (domestic and foreign), high-net-worth individuals, and the public. The quality of management is critical for navigating the complexities of the chemical industry, including R&D, operations, regulatory compliance, and market strategy.
Outlook
Seya Industries operates within the dynamic and essential Indian chemical sector. The industry benefits from strong domestic demand, government support for manufacturing, and global supply chain realignments, offering potential for growth. However, the company's performance is intrinsically linked to the health of its end-user industries and is subject to significant risks such as volatile raw material prices, stringent environmental regulations, and intense competition. Its ability to capitalize on industry growth will depend on effective management of production costs, product innovation, capacity utilization, and maintaining strong customer relationships. Success will hinge on strategic investments, operational efficiency, and adaptability to evolving market and regulatory landscapes.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2 | 3 | 2 | 0 | -5 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 3 | 3 | 2 | 3 | 6 | 5 | 4 | 4 | 4 | 4 |
| Total Income | 5 | 6 | 5 | 3 | 1 | 5 | 4 | 4 | 4 | 4 |
| Total Expenditure | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Operating Profit | 4 | 5 | 4 | 3 | -0 | 4 | 3 | 3 | 3 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 4 | 4 | 5 | 5 | 4 | 6 | 4 | 4 | 4 | 4 |
| Exceptional Income / Expenses | 0 | -1 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | -1 | -1 | -2 | -5 | -3 | -1 | -1 | -1 | -1 |
| Provision for Tax | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | -0 | -1 |
| Profit After Tax | -0 | -0 | -0 | -1 | -4 | -2 | -1 | -1 | -1 | -1 |
| Adjustments | 0 | 0 | 0 | -0 | -0 | -0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | -0 | -0 | -0 | -1 | -4 | -2 | -1 | -1 | -1 | -1 |
| Adjusted Earnings Per Share | -0.1 | -0 | -0.1 | -0.6 | -1.7 | -0.7 | -0.3 | -0.2 | -0.3 | -0.3 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 248 | 275 | 309 | 346 | 413 | 258 | 44 | 66 | 37 | 8 | 0 | 0 |
| Other Income | 1 | 2 | 1 | 1 | 2 | 9 | 8 | 8 | 9 | 9 | 15 | 16 |
| Total Income | 248 | 277 | 309 | 347 | 415 | 267 | 52 | 73 | 46 | 17 | 15 | 16 |
| Total Expenditure | 214 | 227 | 235 | 241 | 275 | 190 | 45 | 56 | 54 | 4 | 5 | 3 |
| Operating Profit | 34 | 50 | 75 | 106 | 140 | 77 | 8 | 17 | -8 | 13 | 10 | 12 |
| Interest | 10 | 13 | 14 | 18 | 18 | 8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 11 | 11 | 14 | 15 | 16 | 17 | 18 | 18 | 18 | 18 | 18 | 16 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -100 | -6 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 14 | 26 | 47 | 74 | 106 | 52 | -110 | -7 | -26 | -5 | -8 | -4 |
| Provision for Tax | 1 | -0 | 5 | 21 | 18 | 5 | -1 | -1 | -1 | -2 | -2 | -3 |
| Profit After Tax | 13 | 27 | 42 | 52 | 88 | 47 | -110 | -6 | -25 | -3 | -6 | -4 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 13 | 27 | 42 | 52 | 88 | 47 | -110 | -6 | -25 | -3 | -6 | -4 |
| Adjusted Earnings Per Share | 11.8 | 23 | 20.8 | 21.3 | 36 | 19.1 | -41.2 | -2.4 | -9.3 | -1.3 | -2.4 | -1.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -100% | -100% | -100% | -100% |
| Operating Profit CAGR | -23% | -16% | -34% | -12% |
| PAT CAGR | 0% | 0% | NAN% | NAN% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -35% | -25% | -28% | -25% |
| ROE Average | -1% | -1% | -3% | 8% |
| ROCE Average | -1% | -1% | -2% | 3% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 216 | 240 | 371 | 740 | 929 | 972 | 862 | 856 | 831 | 828 | 821 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 139 | 347 | 327 | 455 | 617 | 692 | 695 | 690 | 693 | 694 | 696 |
| Other Non-Current Liabilities | 190 | 57 | -5 | -3 | -9 | 12 | 69 | 16 | 13 | 0 | 0 |
| Total Current Liabilities | 65 | 62 | 87 | 117 | 65 | 112 | 112 | 95 | 91 | 91 | 90 |
| Total Liabilities | 611 | 707 | 780 | 1310 | 1602 | 1787 | 1738 | 1657 | 1628 | 1612 | 1608 |
| Fixed Assets | 355 | 397 | 422 | 742 | 731 | 741 | 723 | 706 | 688 | 670 | 652 |
| Other Non-Current Assets | 146 | 162 | 217 | 380 | 687 | 829 | 913 | 896 | 907 | 913 | 929 |
| Total Current Assets | 109 | 148 | 141 | 188 | 184 | 217 | 103 | 55 | 32 | 29 | 27 |
| Total Assets | 611 | 707 | 780 | 1310 | 1602 | 1787 | 1738 | 1657 | 1628 | 1612 | 1608 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 16 | 2 | 0 | 1 | 14 | 2 | 1 | 1 | 2 | 1 | 1 |
| Cash Flow from Operating Activities | 14 | 16 | 69 | 74 | 95 | 2 | -9 | 12 | -13 | -10 | -17 |
| Cash Flow from Investing Activities | -59 | -71 | -137 | -169 | -287 | -84 | 7 | -7 | 9 | 9 | 15 |
| Cash Flow from Financing Activities | 31 | 55 | 68 | 109 | 180 | 81 | 2 | -5 | 3 | 1 | 2 |
| Net Cash Inflow / Outflow | -15 | 0 | 0 | 13 | -13 | -1 | -0 | 1 | -1 | -0 | -0 |
| Closing Cash & Cash Equivalent | 2 | 2 | 1 | 14 | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 11.85 | 22.97 | 20.75 | 21.3 | 35.97 | 19.11 | -41.24 | -2.36 | -9.29 | -1.31 | -2.37 |
| CEPS(Rs) | 21.44 | 34.29 | 27.47 | 27.44 | 42.47 | 25.87 | -34.51 | 4.38 | -2.53 | 5.46 | 4.39 |
| DPS(Rs) | 0 | 1 | 1 | 1 | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 59.22 | 80.56 | 147.46 | 300.95 | 335.75 | 394.18 | 324.44 | 322.07 | 312.79 | 311.48 | 309.11 |
| Core EBITDA Margin(%) | 13.22 | 16.37 | 23.53 | 30.3 | 33.49 | 26.23 | -1.88 | 14.14 | -46.34 | 46.37 | 0 |
| EBIT Margin(%) | 9.33 | 13.28 | 19.45 | 26.26 | 30.14 | 23.19 | -250.49 | -11.05 | -70.35 | -64.11 | 0 |
| Pre Tax Margin(%) | 5.42 | 8.97 | 14.95 | 21.13 | 25.74 | 20.13 | -251 | -11.29 | -70.4 | -64.11 | 0 |
| PAT Margin (%) | 5.15 | 9.08 | 13.44 | 15.06 | 21.44 | 18.21 | -248.98 | -9.57 | -66.5 | -43.09 | 0 |
| Cash Profit Margin (%) | 9.31 | 12.79 | 17.8 | 19.4 | 25.31 | 24.65 | -208.32 | 17.71 | -18.14 | 179.92 | 0 |
| ROA(%) | 2.33 | 4.07 | 5.68 | 5.01 | 6.08 | 2.77 | -6.22 | -0.37 | -1.5 | -0.21 | -0.39 |
| ROE(%) | 22.23 | 34.84 | 21.73 | 10.07 | 11.3 | 5.24 | -11.96 | -0.69 | -2.93 | -0.42 | -0.77 |
| ROCE(%) | 6.18 | 7.51 | 8.76 | 8.91 | 8.62 | 3.59 | -6.54 | -0.43 | -1.62 | -0.32 | -0.51 |
| Receivable days | 43.21 | 73.56 | 84.58 | 95.84 | 90.67 | 160.42 | 600.11 | 359.87 | 22.99 | 13.73 | 0 |
| Inventory Days | 49.15 | 43.42 | 34.62 | 33.77 | 28.57 | 40.5 | 187.89 | 133.65 | 145.97 | 339.14 | 0 |
| Payable days | 7.61 | 7.21 | 15.9 | 24.62 | 16.42 | 17.35 | 71.28 | 49.11 | 13.03 | 0 | 0 |
| PER(x) | 0 | 5.99 | 14.37 | 27.29 | 12.73 | 2.22 | 0 | 0 | 0 | 0 | 0 |
| Price/Book(x) | 0 | 1.71 | 2.02 | 1.93 | 1.36 | 0.11 | 0.15 | 0.11 | 0.07 | 0.06 | 0.04 |
| Dividend Yield(%) | 0 | 0.73 | 0.34 | 0.17 | 0.33 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.82 | 2.52 | 3.22 | 5.67 | 4.34 | 3.38 | 20.49 | 13.08 | 22.23 | 102 | 0 |
| EV/Core EBITDA(x) | 5.93 | 13.85 | 13.31 | 18.43 | 12.77 | 11.41 | 119.99 | 50.71 | -101.13 | 64.19 | 82.69 |
| Net Sales Growth(%) | 88.57 | 11.17 | 12.11 | 12.17 | 19.25 | -37.45 | -82.95 | -74.57 | -43.47 | -78.29 | -100 |
| EBIT Growth(%) | 232.58 | 65.79 | 56 | 49.56 | 36.18 | -51.87 | -284.1 | -112.11 | -259.88 | 80.21 | -58.91 |
| PAT Growth(%) | 288.28 | 105.54 | 57.68 | 24.07 | 68.88 | -46.86 | -333.05 | -113.36 | -292.87 | 85.93 | -81.65 |
| EPS Growth(%) | 288.28 | 93.93 | -9.67 | 2.63 | 68.88 | -46.86 | -315.77 | 94.27 | -292.88 | 85.93 | -81.65 |
| Debt/Equity(x) | 2.97 | 1.64 | 1.3 | 0.74 | 0.81 | 0.79 | 0.89 | 0.9 | 0.93 | 0.93 | 0.94 |
| Current Ratio(x) | 1.69 | 2.39 | 1.63 | 1.6 | 2.83 | 1.94 | 0.91 | 0.58 | 0.35 | 0.32 | 0.29 |
| Quick Ratio(x) | 1.04 | 1.93 | 1.27 | 1.32 | 2.35 | 1.71 | 0.74 | 0.35 | 0.27 | 0.24 | 0.21 |
| Interest Cover(x) | 2.38 | 3.08 | 4.32 | 5.12 | 6.84 | 7.56 | -494.17 | -45.51 | -1388.68 | 0 | 0 |
| Total Debt/Mcap(x) | 0 | 2.6 | 0.64 | 0.38 | 0.59 | 7.36 | 5.8 | 8.12 | 13.5 | 14.71 | 22.04 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Public | 35.44 | 35.44 | 35.43 | 35.43 | 35.43 | 35.43 | 35.43 | 35.43 | 35.43 | 35.43 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -100% | -100% | -100% | -100% |
| Operating Profit CAGR | -23% | -16% | -34% | -12% |
| PAT CAGR | — | — | 0% | 0% |
| Share Price CAGR | -35% | -25% | -28% | -25% |
| ROE Average | -1% | -1% | -3% | +8% |
| ROCE Average | -1% | -1% | -2% | +3% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 | 64.5 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 | 0.07 |
| Public | 35.44 | 35.44 | 35.43 | 35.43 | 35.43 | 35.43 | 35.43 | 35.43 | 35.43 | 35.43 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 | 1.71 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 | 2.66 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.